A cost containment program targeting home infusion drug therapy.
A program was instituted to determine if retrospective, concurrent, and prospective analysis of home infusion therapy cases by a multidisciplinary team comprising clinicians and financial analysts would lead to cost reductions and cost-effective behavioral changes by providers. Actual invoices and prospective price quotes for infusion therapy were reviewed and compared to a database of "usual and customary" prices. The results were presented to providers with the intent of obtaining a reduction in prices for the services rendered or about to be rendered. As a result, $3,265,248 in short-term cost reductions were achieved, and $15,146,789 in long-term cost reductions are projected. Analysis resulted in average cost reductions of $2,247 and $10,424 respectively. Very significant cost reductions can be achieved through the use of a multidisciplinary team and a comprehensive pricing database for home infusion therapy.